Alveolar bone loss one year following ovariectomy in sheep.
There is little information concerning the incidence of alveolar bone loss in estrogen-deficient women. Ovariectomized sheep are valid models for study of the effects of estrogen deficiency on bone metabolism. The objective of this study was to compare alveolar bone loss in control (C) and ovariectomized sheep (OVX) at 3 and 12 months following surgery. OVX animals had decreased serum levels of 17-beta-estradiol and increased serum levels of osteocalcin, IL-6, and urinary levels of deoxypyridinoline which, taken together, suggest development of osteoporosis. The mean probing depths and percentage of sites with pocket depths 4 to 6 mm and > 6 mm were significantly greater in OVX than C at each time period and in OVX were significantly greater at 12 months that at 3 months. Gingival tissue interleukin-6 (IL-6) levels (but not the number of IL-6(+) cells) were elevated adjacent to deep periodontal pockets; however, there was no significant elevation of levels of the proinflammatory cytokines IL-1 beta and IL-8 within gingiva. Taken together, the data suggest a systemic contribution for progression of periodontal disease associated with estrogen deficiency. This may involve upregulation of systemic IL-6 synthesis and transfer to gingiva in serum, resulting in enhanced IL-6 accumulation within the gingival tissues or reduced bone density allowing for a greater amount of alveolar bone loss.
Johnson
R B
RB
Department of Periodontics, University of Mississippi School of Dentistry, Jackson, USA.
Gilbert
J A
JA
Cooper
R C
RC
Dai
X
X
Newton
B I
BI
Tracy
R R
RR
West
W F
WF
DeMoss
T L
TL
Myers
P J
PJ
Streckfus
C F
CF
D016301:Alveolar Bone Loss / Q000000981:diagnostic imaging / Q000209:etiology*; D000596:Amino Acids / Q000652:urine; D000818:Animals; D015415:Biomarkers / Q000652:urine; D015519:Bone Density; D001842:Bone and Bones / Q000378:metabolism; D004195:Disease Models, Animal; D018450:Disease Progression; D004958:Estradiol / Q000097:blood; D004967:Estrogens / Q000097:blood / Q000172:deficiency; D005260:Female; D005500:Follow-Up Studies; D005881:Gingiva / Q000276:immunology; D007375:Interleukin-1 / Q000032:analysis; D015850:Interleukin-6 / Q000032:analysis / Q000096:biosynthesis / Q000097:blood; D016209:Interleukin-8 / Q000032:analysis; D008334:Mandible / Q000000981:diagnostic imaging / Q000503:physiopathology; D008337:Mandibular Fractures / Q000209:etiology / Q000503:physiopathology; D015675:Osteocalcin / Q000097:blood; D010024:Osteoporosis / Q000097:blood / Q000000981:diagnostic imaging / Q000209:etiology / Q000503:physiopathology / Q000652:urine; D010052:Ovariectomy; D010053:Ovary / Q000502:physiology; D010514:Periodontal Pocket / Q000209:etiology / Q000276:immunology; D011859:Radiography; D012756:Sheep; D013314:Stress, Mechanical; D015854:Up-Regulation
D000596:Amino Acids; D015415:Biomarkers; D004967:Estrogens; D007375:Interleukin-1; D015850:Interleukin-6; D016209:Interleukin-8; D015675:Osteocalcin; D004958:Estradiol; C036020:deoxypyridinoline